| Literature DB >> 29119076 |
Christian Lausmann1, Akos Zahar1, Mustafa Citak1, Julian Brañes2, Stefan Schmidl1, Lars Frommelt1, Thorsten Gehrke1, Matthias Gebauer1.
Abstract
Purpose Identification of bacteria and susceptibility are fundamental in periprosthetic joint infection (PJI). Especially in the case of systemic inflammatory response syndrome (SIRS) rapid detection of pathogens is essential for proper therapy. Bacterial cultures are time consuming. The polymerase chain reaction (PCR) is a non-culture molecular method and is able to rapidly identify pathogens and their resistance genes. Multiplex PCR (mPCR) can amplify several different DNA sequences simultaneously. The aim of this study was to show the value of mPCR for early diagnosis of PJI. Methods 60 patients undergoing total hip or knee revisions were recruited in this prospective single-centre-study. Three groups were created: 26 patients with aseptic loosening (negative control), 26 patients with chronic PJI, and 8 patients with acute PJI/SIRS. We compared the results of joint aspirates obtained intraoperatively investigated by mPCR with the microbiology results of tissue specimens. Results The overall sensitivity of mPCR was 78.8% (95% CI, 61.1 - 91.0%), the specificity was 100% (95% CI, 87.2 - 100%), the negative predictive value was 79.4% (95% CI, 62.1 - 91.3%), the positive predictive value was 100% (95% CI, 86.8 - 100%), and the overall accuracy was 88.3% (95% CI, 77.4 - 95.2%). The overall accuracy in acute infections/SIRS (87.5%) was greater than in late chronic PJI (76.9%). In PJI the mPCR was able to provide the results within 5 hours whereas the mean time for cultures was 6.4 days. Conclusions Multiplex PCR is a reliable diagnostic tool in PJI management, especially in acute cases complicated with SIRS. Early diagnosis within several hours is possible, targeted antibiotic treatment can be started promptly.Entities:
Keywords: bacteria; diagnosis; polymerase chain reaction; prosthetic joint infection; revision arthroplasty.; susceptibility
Year: 2017 PMID: 29119076 PMCID: PMC5671930 DOI: 10.7150/jbji.22062
Source DB: PubMed Journal: J Bone Jt Infect ISSN: 2206-3552
Number and distribution of bacteria detected with the Curetis Unyvero® multiplex PCR (polymerase chain reaction) system in patients with chronic or acute prosthetic joint infection (study groups B and C)
| Pathogen detected | Number | Distribution % |
|---|---|---|
| Coagulase negative Staphylococci | 14 | 41.2 |
| 5 | 14.7 | |
| 2 | 5.9 | |
| 2 | 5.9 | |
| 2 | 5.9 | |
| 1 | 2.9 | |
| Negative | 8 | 23.5 |
| TOTAL | 34 | 100 |
Figure 1Coverage of the clinically relevant pathogens detected by the Unyvero® Multiplex PCR cartridge system. The most relevant pathogens and their sub-groups which have been reported in studies are shown. Modified account based on Curetis Unyvero®.
Results of all study patients (n=60): the most important parameters of negative control patients (Group A), of patients with chronic PJI (Group B) and of individuals with acute PJI complicated with SIRS (Group C) are shown. Mismatch between results of mPCR and traditional cultures are highlighted with grey color. [CRP = C-reactive protein, LE = leukocyte esterase, mPCR = multiplex polymerase chain reaction, TKA = total knee arthroplasty, THA = total hip arthroplasty, Neg. = negative result, Hem. = hemorrhagic, CNS = coagulase negative Staphylococci]
| Group | Age (ys.) | Joint | CRP (mg/L) | LE test | mPCR | Culture aspiration | Culture tissue sample | Preoperative antibiotics |
|---|---|---|---|---|---|---|---|---|
| 75 | TKA | 1.3 | Neg. | Neg. | Neg. | Neg. | none | |
| 69 | TKA | 5.9 | Neg. | Neg. | Neg. | Neg. | none | |
| 72 | THA | 1.4 | Neg. | Neg. | Neg. | Neg. | none | |
| 60 | THA | 1.8 | Neg. | Neg. | Neg. | Neg. | none | |
| 66 | TKA | 1.4 | Neg. | Neg. | Neg. | Neg. | none | |
| 73 | THA | 4.9 | Neg. | Neg. | Neg. | Neg. | none | |
| 86 | THA | 0.5 | Neg. | Neg. | Neg. | Neg. | none | |
| 77 | TKA | 1.3 | Neg. | Neg. | Neg. | Neg. | none | |
| 80 | TKA | 1.8 | Neg. | Neg. | Neg. | Neg. | none | |
| 71 | TKA | 2.6 | Neg. | Neg. | Neg. | Neg. | none | |
| 75 | THA | 2.2 | Neg. | Neg. | Neg. | Neg. | none | |
| 67 | TKA | 3.3 | Neg. | Neg. | Neg. | Neg. | none | |
| 65 | THA | 4.9 | Neg. | Neg. | Neg. | Neg. | none | |
| 54 | TKA | 4.8 | Neg. | Neg. | Neg. | Neg. | none | |
| 65 | TKA | 2.1 | Neg. | Neg. | Neg. | Neg. | none | |
| 81 | TKA | 5.6 | Neg. | Neg. | Neg. | Neg. | none | |
| 55 | TKA | 0.6 | Hem. | Neg. | Neg. | Neg. | none | |
| 57 | TKA | 2.1 | Neg. | Neg. | Neg. | Neg. | none | |
| 79 | THA | 0.4 | + | Neg. | Neg. | Neg. | none | |
| 80 | TKA | 0.3 | Neg. | Neg. | Neg. | Neg. | none | |
| 76 | TKA | 1.4 | Neg. | Neg. | Neg. | Neg. | none | |
| 74 | TKA | 1.0 | Neg. | Neg. | Neg. | Neg. | none | |
| 76 | TKA | 0.8 | Neg. | Neg. | Neg. | Neg. | none | |
| 87 | THA | 1.0 | Neg. | Neg. | Neg. | Neg. | none | |
| 75 | TKA | 7.8 | Neg. | Neg. | Neg. | Neg. | none | |
| 66 | THA | 1.2 | Neg. | Neg. | Neg. | Neg. | none | |
| 56 | THA | 13.5 | +++ | P. acnes | P. acnes | P. acnes | Vancomycin / Meropenem | |
| 76 | THA | 23.7 | +++ | CNS | S. epidermidis | S. epidermidis | none | |
| 73 | TKA | 65.3 | +++ | CNS | S. epidermidis | S. epidermidis | none | |
| 74 | THA | 47.5 | +++ | CNS | Neg. | S. epidermidis | none | |
| 71 | THA | 36.3 | ++ | Neg. | P. acnes | P. acnes | none | |
| 69 | TKA | 58.2 | ++ | Neg. | S. aureus | S. aureus | none | |
| 75 | TKA | 19.6 | +++ | E. faecalis | E. faecalis | E. faecalis | none | |
| 68 | TKA | 79.4 | +++ | CNS | S. epidermidis | S. epidermidis | none | |
| 54 | THA | 1.9 | +++ | CNS | S. capitis | S. capitis | none | |
| 41 | THA | 18.2 | +++ | S. agalactiae | S. epidermidis | S. epidermidis | none | |
| 74 | THA | 66.9 | +++ | Neg. | S. anginosus | S. anginosus | none | |
| 57 | THA | 45.1 | +++ | CNS | S. capitis | S. capitis | none | |
| 78 | TKA | 27.7 | +++ | CNS | S. epidermidis | S. epidermidis | none | |
| 80 | TKA | 28.4 | +++ | S. aureus | S. aureus | S. aureus | none | |
| 70 | THA | 8.5 | +++ | S. aureus | S. aureus | S. aureus | none | |
| 52 | TKA | 33.5 | +++ | Neg. | Neg. | S. epidermidis | none | |
| 72 | TKA | 9.3 | +++ | Neg. | Neg. | S. epidermidis | none | |
| 62 | TKA | 20.7 | +++ | CNS | Neg. | S. epidermidis | none | |
| 65 | THA | 41.8 | +++ | CNS | S. epidermidis | S. epidermidis | none | |
| 59 | THA | 6.0 | +++ | P. acnes | P. acnes | P. acnes | none | |
| 63 | THA | 8.0 | +++ | Neg. | Neg. | S. epidermidis | none | |
| 74 | TKA | 14.4 | ++ | E. faecalis | E. faecalis | E. faecalis | none | |
| 83 | THA | 88.7 | +++ | S. aureus | S. aureus | S. aureus | none | |
| 62 | THA | 16.9 | +++ | CNS | S. lugdunensis | S. lugdunensis | none | |
| 57 | THA | 5.9 | +++ | CNS | S. capitis | S. capitis | none | |
| 76 | THA | 40.8 | +++ | CNS | S. capitis | S. capitis | none | |
| 57 | THA | 106.0 | +++ | CNS | Neg. | S. epidermidis | Vancomycin / Meropenem | |
| 57 | TKA | 100.0 | +++ | Neg. | Neg. | S. epidermidis | none | |
| 82 | TKA | 284.0 | +++ | S. aureus | S. aureus | S. aureus | Vancomycin / Meropenem | |
| 69 | TKA | 164.0 | +++ | Neg. | Neg. | Neg. | Cefuroxim | |
| 77 | THA | 75.5 | +++ | E. cloacae | Neg. | E. cloacae | none | |
| 84 | THA | 122.0 | +++ | S. aureus | S. aureus | S. aureus | none | |
| 79 | THA | 358.5 | +++ | CNS | S. epidermidis | S. epidermidis | none | |
| 80 | THA | 258.8 | +++ | E. cloacae | E. cloacae | E. cloacae | none |
Overview of the statistical evaluation of the entire study group. [mPCR = Multiplex Poymerase Chain Reaction, - = negative mPCR result, + = positive mPCR result, CI = Confidence Interval, NPV = negative predictive value, PPV = positive predictive value, OA = overall accuracy]
| mPCR | ||
|---|---|---|
| - | + | |
| 95 % CI | ||
| Culture negative | 27 | 0 |
| Culture positive | 7 | 26 |
| Sensitivity | 78.8 % [61.1 - 91.0 %] | |
| Specificity | 100 % [87.2 - 100 %] | |
| NPV | 79.4 % [62.1 - 91.3 %] | |
| PPV | 100 % [86.8 - 100 %] | |
| OA | 88.3 % [77.4 - 95.2 %] | |